Organisation paid for research Program year 2022 Source: CMS Open Payments

Biotrial Inc

Neither a doctor nor a teaching hospital

Research payments

$944,244

12 payments

Through program year 2022, Biotrial Inc is reported as receiving $944,244 in research payments, across 12 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$332,553	3
2021	Research	$560,014	7
2020	Research	$51,677	2

Breakdown

Who paid Research payments · program years 2020–2022

Becton, Dickinson and Company $796,753 10 payments
Genzyme Corporation $146,089 1 payment
Sanofi US Services Inc. $1,402 1 payment

Studies the money was for Research payments · program years 2020–2022

Sust036 $635,672 6 payments
Tolerance Rep. Dose-Anti FGFR3 $146,089 1 payment
Sust040 $124,480 2 payments
Sust047 $28,900 1 payment
Sust037 $7,700 1 payment
A Phase 1b, Randomized, Double-blinded, Placebo-controlled Study of Hydroxychloroquine in Outpatient Adults With COVID-19 $1,402 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.